You are here

  • Home
  • Archive
  • Volume 23, Issue 6
  • Does use of ‘non-trial’ cessation support help explain the lack of effect from offering NRT to quitline callers in a RCT?

Article info

Article menu

Download PDFPDF

Research letter
Does use of ‘non-trial’ cessation support help explain the lack of effect from offering NRT to quitline callers in a RCT?

Authors

  • Graeme Docherty Department of Epidemiology and Public Health, UK Centre for Tobacco Control Studies, University of Nottingham, Nottingham, UK PubMed articlesGoogle scholar articles
  • Sarah Lewis Department of Epidemiology and Public Health, UK Centre for Tobacco Control Studies, University of Nottingham, Nottingham, UK PubMed articlesGoogle scholar articles
  • Andy McEwen Department of Epidemiology and Public Health, Cancer Research UK Health Behaviour Research Centre, UK Centre for Tobacco Control Studies, University College London, London, UK PubMed articlesGoogle scholar articles
  • Linda Bauld UK Centre for Tobacco Control Studies, Institute of Social Marketing, University of Stirling, Stirling, UK PubMed articlesGoogle scholar articles
  • Tim Coleman Division of Primary Care, UK Centre for Tobacco Control Studies and NIHR School for Primary Care Research, University of Nottingham, Queen's Medical Centre, Nottingham, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Graeme Docherty, Department of Epidemiology and Public Health, UK Centre for Tobacco Control Studies, University of Nottingham, C100, Clinical Sciences Building, City Hospital, Hucknall Road, Nottingham NG5 1PB, UK; graeme.docherty{at}nottingham.ac.uk
View Full Text

Citation

Docherty G, Lewis S, McEwen A, et al
Does use of ‘non-trial’ cessation support help explain the lack of effect from offering NRT to quitline callers in a RCT?
Tobacco Control 2014;23:524-525.

Publication history

  • Accepted June 2, 2013
  • First published July 23, 2013.
Online issue publication 
May 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/3.0/